Trial Details
COMPLETEDBasic Information
| Clinical ID | c4517 |
|---|---|
| Identifier | NCT00394173 |
| Trial Title | Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea (IBS-D) |
| Interventions | DRUG: DNK333|DRUG: Placebo |
Participant Information
| Sponsor | Novartis |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-09 |
|---|---|
| Primary Completion Date | 2007-10 |
| Completion Date | 2007-10 |